Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Cyfuse Biomedical K.K., Tokyo, Japan.
Tissue Eng Part A. 2020 Mar;26(5-6):350-357. doi: 10.1089/ten.TEA.2019.0313.
Tissue engineering is an essential component of developing effective regenerative therapies. In this study, we introduce a promising method to create scaffold-free three-dimensional (3D) tissue engineered multilayered microstructures from cultured cells using the "3D tissue fabrication system" (Regenova; Cyfuse, Tokyo, Japan). This technique utilizes the adhesive nature of cells. When cells are cultured in nonadhesive wells, they tend to aggregate and form a spheroidal structure. The advantage of this approach is that cellular components can be mixed into one spheroid, thereby promoting the formation of extracellular matrices, such as collagen and elastin. This system enables one to create a predesigned 3D structure composed of cultured cells. We found that the advantages of this system to be (1) the length, size, and shape of the structure that were designable and highly reproducible because of the computer controlled robotics system, (2) the graftable structure could be created within a reasonable period (8 days), and (3) the constructed tissue did not contain any foreign material, which may avoid the potential issues of contamination, biotoxicity, and allergy. The utilization of this robotic system enabled the creation of a 3D multilayered microstructure made of cell-based spheres with a satisfactory mechanical properties and abundant extracellular matrix during a short period of time. These results suggest that this new technology will represent a promising, attractive, and practical strategy in the field of tissue engineering. Impact statement The utilization of the "three dimensional tissue fabrication system" enabled the creation of a three-dimensional (3D) multilayered microstructure made of cell-based spheres with a satisfactory mechanical properties and abundant extracellular matrix during a short period of time. These results suggest that this new technology will represent a promising, attractive, and practical strategy in the field of tissue engineering.
组织工程是开发有效再生疗法的重要组成部分。在这项研究中,我们介绍了一种有前途的方法,使用“3D 组织制造系统”(Regenova;Cyfuse,东京,日本)从培养细胞中创建无支架的三维(3D)组织工程多层微结构。该技术利用细胞的粘附特性。当细胞在非粘附孔中培养时,它们往往会聚集并形成球形结构。这种方法的优点是细胞成分可以混合到一个球体中,从而促进细胞外基质(如胶原和弹性蛋白)的形成。该系统可以创建由培养细胞组成的预定 3D 结构。我们发现该系统具有以下优点:(1)由于计算机控制的机器人系统,结构的长度、大小和形状是可设计的且高度可重复的;(2)可以在合理的时间内(8 天)创建可移植的结构;(3)构建的组织不包含任何可能避免污染、生物毒性和过敏等潜在问题的异物。该机器人系统的使用使我们能够在短时间内创建具有满意机械性能和丰富细胞外基质的基于细胞球体的 3D 多层微结构。这些结果表明,这项新技术将代表组织工程领域有前途、有吸引力和实用的策略。